Core Viewpoint - The implementation plan for the comprehensive reform of drug, medical device, and cosmetic regulation in Hainan Province aims to promote high-quality development of the pharmaceutical industry through various supportive measures for innovative drugs and medical devices [1] Group 1: Support for Innovative Drugs and Devices - The plan includes timely updates to the "Hainan Province Innovative Drug and Device Product Directory," allowing new drugs, first-generic drugs, and generics that pass quality and efficacy consistency evaluations, as well as certain classes of medical devices, to be included for procurement by medical institutions [1] - There is an emphasis on accelerating the use of innovative drugs and devices in hospitals by establishing a long-term mechanism for regular meetings of pharmacy, device management, and pharmacotherapy committees in public hospitals [1] - The initiative aims to facilitate the inclusion of innovative drugs and devices in the national medical insurance negotiations, providing guidance to companies to help eligible products enter the insurance directory [1] Group 2: Pricing and Market Access - A mechanism for the formation of initial pricing and full-cycle price management for innovative medical devices will be established, promoting rapid online trading through price negotiation between supply and demand parties for devices without listed prices [1]